NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage [Yahoo! Finance]
Neuraxis, Inc. (NRXS)
Company Research
Source: Yahoo! Finance
This strong performance contrasts with the S&P 500 index, which saw a decline of 0.9% during the same period. Over the past month, NeurAxis stock has risen 17.7%, outperforming the S&P 500's 2.1% gain. NeurAxis reported revenues of $0.7 million in third-quarter 2024, marking a 39.6% increase from $0.5 million in third-quarter 2023. Gross profit grew 38.9% year over year to $0.6 million. Gross margin saw a slight decline of 50 basis points from 85.9% in third-quarter 2023 to 85.4% in the reported quarter. This is due to higher growth in the company's financial assistance programs that are discounted to patients without insurance coverage compared to the company's undiscounted full reimbursement customers. Operating loss improved significantly to $1.7 million in third-quarter 2024 from $3 million in third-quarter 2023. Net loss for the quarter was $1.8 million, a substantial improvement from the $8.6 million loss reported in third-quarter 2023. Loss per share was reduced to $0.25 in
Show less
Read more
Impact Snapshot
Event Time:
NRXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRXS alerts
High impacting Neuraxis, Inc. news events
Weekly update
A roundup of the hottest topics
NRXS
News
- NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues [Yahoo! Finance]Yahoo! Finance
- NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesGlobeNewswire
- NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024GlobeNewswire
- NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable MarketGlobeNewswire
- NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024GlobeNewswire
NRXS
Sec Filings
- 11/15/24 - Form 8-K
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- NRXS's page on the SEC website